nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—type 2 diabetes mellitus	0.271	1	CbGaD
Brinzolamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0407	0.152	CbGbCtD
Brinzolamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0363	0.136	CbGbCtD
Brinzolamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0332	0.124	CbGbCtD
Brinzolamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.029	0.109	CbGbCtD
Brinzolamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0262	0.0982	CbGbCtD
Brinzolamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0199	0.0744	CbGbCtD
Brinzolamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0191	0.0713	CbGbCtD
Brinzolamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0191	0.0713	CbGbCtD
Brinzolamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.018	0.0675	CbGbCtD
Brinzolamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0134	0.0503	CbGbCtD
Brinzolamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.0123	0.046	CbGbCtD
Brinzolamide—CA1—nerve—type 2 diabetes mellitus	0.00265	0.0877	CbGeAlD
Brinzolamide—CA9—islet of Langerhans—type 2 diabetes mellitus	0.00219	0.0725	CbGeAlD
Brinzolamide—CA4—nerve—type 2 diabetes mellitus	0.00207	0.0685	CbGeAlD
Brinzolamide—CA7—kidney—type 2 diabetes mellitus	0.00177	0.0584	CbGeAlD
Brinzolamide—Dorzolamide—CYP3A4—type 2 diabetes mellitus	0.00168	1	CrCbGaD
Brinzolamide—CA5A—liver—type 2 diabetes mellitus	0.00168	0.0555	CbGeAlD
Brinzolamide—CA12—kidney—type 2 diabetes mellitus	0.00115	0.0379	CbGeAlD
Brinzolamide—CA5B—cardiovascular system—type 2 diabetes mellitus	0.00105	0.0348	CbGeAlD
Brinzolamide—CA5B—pancreas—type 2 diabetes mellitus	0.00102	0.0338	CbGeAlD
Brinzolamide—CA4—islet of Langerhans—type 2 diabetes mellitus	0.001	0.0332	CbGeAlD
Brinzolamide—CA14—liver—type 2 diabetes mellitus	0.00093	0.0307	CbGeAlD
Brinzolamide—CA1—cardiovascular system—type 2 diabetes mellitus	0.000929	0.0307	CbGeAlD
Brinzolamide—CA5B—adipose tissue—type 2 diabetes mellitus	0.000928	0.0307	CbGeAlD
Brinzolamide—CA1—kidney—type 2 diabetes mellitus	0.000909	0.03	CbGeAlD
Brinzolamide—CA1—pancreas—type 2 diabetes mellitus	0.000903	0.0298	CbGeAlD
Brinzolamide—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000833	0.0275	CbGeAlD
Brinzolamide—CA1—adipose tissue—type 2 diabetes mellitus	0.000819	0.0271	CbGeAlD
Brinzolamide—CA4—nephron tubule—type 2 diabetes mellitus	0.000808	0.0267	CbGeAlD
Brinzolamide—CA4—cardiovascular system—type 2 diabetes mellitus	0.000726	0.024	CbGeAlD
Brinzolamide—CA2—retina—type 2 diabetes mellitus	0.000712	0.0235	CbGeAlD
Brinzolamide—CA4—kidney—type 2 diabetes mellitus	0.00071	0.0235	CbGeAlD
Brinzolamide—CA4—cortex of kidney—type 2 diabetes mellitus	0.000692	0.0229	CbGeAlD
Brinzolamide—CA2—nephron tubule—type 2 diabetes mellitus	0.00067	0.0222	CbGeAlD
Brinzolamide—CA4—adipose tissue—type 2 diabetes mellitus	0.00064	0.0212	CbGeAlD
Brinzolamide—CA2—cardiovascular system—type 2 diabetes mellitus	0.000602	0.0199	CbGeAlD
Brinzolamide—CA2—kidney—type 2 diabetes mellitus	0.000589	0.0195	CbGeAlD
Brinzolamide—CA2—pancreas—type 2 diabetes mellitus	0.000585	0.0193	CbGeAlD
Brinzolamide—CA1—liver—type 2 diabetes mellitus	0.000575	0.019	CbGeAlD
Brinzolamide—CA2—cortex of kidney—type 2 diabetes mellitus	0.000574	0.019	CbGeAlD
Brinzolamide—CA2—adipose tissue—type 2 diabetes mellitus	0.000531	0.0176	CbGeAlD
Brinzolamide—CYP3A4—kidney—type 2 diabetes mellitus	0.00038	0.0126	CbGeAlD
Brinzolamide—CA2—liver—type 2 diabetes mellitus	0.000372	0.0123	CbGeAlD
Brinzolamide—CYP3A4—liver—type 2 diabetes mellitus	0.00024	0.00794	CbGeAlD
Brinzolamide—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000208	0.000657	CcSEcCtD
Brinzolamide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000208	0.000657	CcSEcCtD
Brinzolamide—Agitation—Irbesartan—type 2 diabetes mellitus	0.000208	0.000656	CcSEcCtD
Brinzolamide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000208	0.000656	CcSEcCtD
Brinzolamide—Hypertension—Metformin—type 2 diabetes mellitus	0.000207	0.000653	CcSEcCtD
Brinzolamide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000207	0.000653	CcSEcCtD
Brinzolamide—Nervousness—Losartan—type 2 diabetes mellitus	0.000207	0.000652	CcSEcCtD
Brinzolamide—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000206	0.000652	CcSEcCtD
Brinzolamide—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000206	0.000651	CcSEcCtD
Brinzolamide—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000206	0.00065	CcSEcCtD
Brinzolamide—Back pain—Losartan—type 2 diabetes mellitus	0.000206	0.00065	CcSEcCtD
Brinzolamide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000206	0.00065	CcSEcCtD
Brinzolamide—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000205	0.000646	CcSEcCtD
Brinzolamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000204	0.000645	CcSEcCtD
Brinzolamide—Chest pain—Metformin—type 2 diabetes mellitus	0.000204	0.000644	CcSEcCtD
Brinzolamide—Myalgia—Metformin—type 2 diabetes mellitus	0.000204	0.000644	CcSEcCtD
Brinzolamide—Malaise—Irbesartan—type 2 diabetes mellitus	0.000204	0.000644	CcSEcCtD
Brinzolamide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000203	0.000641	CcSEcCtD
Brinzolamide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000203	0.000641	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000203	0.00064	CcSEcCtD
Brinzolamide—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000202	0.000638	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000202	0.000637	CcSEcCtD
Brinzolamide—Discomfort—Metformin—type 2 diabetes mellitus	0.000202	0.000636	CcSEcCtD
Brinzolamide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000202	0.000636	CcSEcCtD
Brinzolamide—Nausea—Glipizide—type 2 diabetes mellitus	0.000201	0.000634	CcSEcCtD
Brinzolamide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000201	0.000634	CcSEcCtD
Brinzolamide—Hypotension—Valsartan—type 2 diabetes mellitus	0.000201	0.000633	CcSEcCtD
Brinzolamide—Vision blurred—Losartan—type 2 diabetes mellitus	0.000201	0.000633	CcSEcCtD
Brinzolamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.0002	0.000632	CcSEcCtD
Brinzolamide—Pain—Gliclazide—type 2 diabetes mellitus	0.0002	0.000631	CcSEcCtD
Brinzolamide—Tremor—Losartan—type 2 diabetes mellitus	0.000199	0.000629	CcSEcCtD
Brinzolamide—Rash—Glimepiride—type 2 diabetes mellitus	0.000199	0.000628	CcSEcCtD
Brinzolamide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000199	0.000628	CcSEcCtD
Brinzolamide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000198	0.000626	CcSEcCtD
Brinzolamide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000198	0.000626	CcSEcCtD
Brinzolamide—Headache—Glimepiride—type 2 diabetes mellitus	0.000198	0.000624	CcSEcCtD
Brinzolamide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000197	0.000623	CcSEcCtD
Brinzolamide—Cough—Irbesartan—type 2 diabetes mellitus	0.000197	0.000623	CcSEcCtD
Brinzolamide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000197	0.000622	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000196	0.000618	CcSEcCtD
Brinzolamide—Agitation—Losartan—type 2 diabetes mellitus	0.000196	0.000617	CcSEcCtD
Brinzolamide—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000195	0.000617	CcSEcCtD
Brinzolamide—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000195	0.000616	CcSEcCtD
Brinzolamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000195	0.000615	CcSEcCtD
Brinzolamide—Infection—Metformin—type 2 diabetes mellitus	0.000194	0.000613	CcSEcCtD
Brinzolamide—Insomnia—Valsartan—type 2 diabetes mellitus	0.000194	0.000613	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000193	0.00061	CcSEcCtD
Brinzolamide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000193	0.000609	CcSEcCtD
Brinzolamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000193	0.000608	CcSEcCtD
Brinzolamide—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000192	0.000608	CcSEcCtD
Brinzolamide—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000192	0.000608	CcSEcCtD
Brinzolamide—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000192	0.000608	CcSEcCtD
Brinzolamide—Insomnia—Orlistat—type 2 diabetes mellitus	0.000192	0.000606	CcSEcCtD
Brinzolamide—Malaise—Losartan—type 2 diabetes mellitus	0.000192	0.000606	CcSEcCtD
Brinzolamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000192	0.000605	CcSEcCtD
Brinzolamide—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000192	0.000605	CcSEcCtD
Brinzolamide—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000191	0.000604	CcSEcCtD
Brinzolamide—Vertigo—Losartan—type 2 diabetes mellitus	0.000191	0.000604	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000191	0.000604	CcSEcCtD
Brinzolamide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000191	0.000603	CcSEcCtD
Brinzolamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000191	0.000602	CcSEcCtD
Brinzolamide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00019	0.0006	CcSEcCtD
Brinzolamide—Skin disorder—Metformin—type 2 diabetes mellitus	0.00019	0.0006	CcSEcCtD
Brinzolamide—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000189	0.000598	CcSEcCtD
Brinzolamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000189	0.000597	CcSEcCtD
Brinzolamide—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000189	0.000596	CcSEcCtD
Brinzolamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000188	0.000594	CcSEcCtD
Brinzolamide—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000188	0.000594	CcSEcCtD
Brinzolamide—Palpitations—Losartan—type 2 diabetes mellitus	0.000188	0.000594	CcSEcCtD
Brinzolamide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000187	0.000592	CcSEcCtD
Brinzolamide—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000187	0.000591	CcSEcCtD
Brinzolamide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000187	0.00059	CcSEcCtD
Brinzolamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000187	0.00059	CcSEcCtD
Brinzolamide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000187	0.00059	CcSEcCtD
Brinzolamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000187	0.000589	CcSEcCtD
Brinzolamide—Cough—Losartan—type 2 diabetes mellitus	0.000186	0.000586	CcSEcCtD
Brinzolamide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000186	0.000586	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000185	0.000585	CcSEcCtD
Brinzolamide—Alopecia—Ramipril—type 2 diabetes mellitus	0.000185	0.000585	CcSEcCtD
Brinzolamide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000185	0.000584	CcSEcCtD
Brinzolamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000184	0.000582	CcSEcCtD
Brinzolamide—Pruritus—Glyburide—type 2 diabetes mellitus	0.000184	0.000581	CcSEcCtD
Brinzolamide—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000184	0.00058	CcSEcCtD
Brinzolamide—Infection—Irbesartan—type 2 diabetes mellitus	0.000183	0.000579	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000183	0.000578	CcSEcCtD
Brinzolamide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000183	0.000578	CcSEcCtD
Brinzolamide—Hypotension—Metformin—type 2 diabetes mellitus	0.000183	0.000577	CcSEcCtD
Brinzolamide—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000182	0.000576	CcSEcCtD
Brinzolamide—Erythema—Ramipril—type 2 diabetes mellitus	0.000182	0.000576	CcSEcCtD
Brinzolamide—Pain—Orlistat—type 2 diabetes mellitus	0.000181	0.000573	CcSEcCtD
Brinzolamide—Arthralgia—Losartan—type 2 diabetes mellitus	0.000181	0.000572	CcSEcCtD
Brinzolamide—Myalgia—Losartan—type 2 diabetes mellitus	0.000181	0.000572	CcSEcCtD
Brinzolamide—Chest pain—Losartan—type 2 diabetes mellitus	0.000181	0.000572	CcSEcCtD
Brinzolamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000181	0.000572	CcSEcCtD
Brinzolamide—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000181	0.000571	CcSEcCtD
Brinzolamide—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00018	0.000569	CcSEcCtD
Brinzolamide—Rash—Bromocriptine—type 2 diabetes mellitus	0.00018	0.000567	CcSEcCtD
Brinzolamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000179	0.000566	CcSEcCtD
Brinzolamide—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000179	0.000566	CcSEcCtD
Brinzolamide—Tension—Ramipril—type 2 diabetes mellitus	0.000179	0.000565	CcSEcCtD
Brinzolamide—Discomfort—Losartan—type 2 diabetes mellitus	0.000179	0.000565	CcSEcCtD
Brinzolamide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000179	0.000564	CcSEcCtD
Brinzolamide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000178	0.000563	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000178	0.000562	CcSEcCtD
Brinzolamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000178	0.000562	CcSEcCtD
Brinzolamide—Nervousness—Ramipril—type 2 diabetes mellitus	0.000177	0.000559	CcSEcCtD
Brinzolamide—Dry mouth—Losartan—type 2 diabetes mellitus	0.000177	0.000559	CcSEcCtD
Brinzolamide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000176	0.000554	CcSEcCtD
Brinzolamide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000175	0.000554	CcSEcCtD
Brinzolamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000175	0.000552	CcSEcCtD
Brinzolamide—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000174	0.00055	CcSEcCtD
Brinzolamide—Somnolence—Metformin—type 2 diabetes mellitus	0.000174	0.000549	CcSEcCtD
Brinzolamide—Infection—Losartan—type 2 diabetes mellitus	0.000173	0.000545	CcSEcCtD
Brinzolamide—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000172	0.000544	CcSEcCtD
Brinzolamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000172	0.000544	CcSEcCtD
Brinzolamide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000172	0.000543	CcSEcCtD
Brinzolamide—Tremor—Ramipril—type 2 diabetes mellitus	0.000171	0.00054	CcSEcCtD
Brinzolamide—Urticaria—Valsartan—type 2 diabetes mellitus	0.000171	0.000539	CcSEcCtD
Brinzolamide—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00017	0.000538	CcSEcCtD
Brinzolamide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00017	0.000537	CcSEcCtD
Brinzolamide—Tachycardia—Losartan—type 2 diabetes mellitus	0.000169	0.000535	CcSEcCtD
Brinzolamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000169	0.000534	CcSEcCtD
Brinzolamide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000169	0.000534	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000169	0.000533	CcSEcCtD
Brinzolamide—Fatigue—Metformin—type 2 diabetes mellitus	0.000169	0.000532	CcSEcCtD
Brinzolamide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000169	0.000532	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000168	0.000531	CcSEcCtD
Brinzolamide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000168	0.000529	CcSEcCtD
Brinzolamide—Agitation—Ramipril—type 2 diabetes mellitus	0.000168	0.000529	CcSEcCtD
Brinzolamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000166	0.000523	CcSEcCtD
Brinzolamide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000165	0.000522	CcSEcCtD
Brinzolamide—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000165	0.000522	CcSEcCtD
Brinzolamide—Malaise—Ramipril—type 2 diabetes mellitus	0.000165	0.000519	CcSEcCtD
Brinzolamide—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000165	0.000519	CcSEcCtD
Brinzolamide—Rash—Glyburide—type 2 diabetes mellitus	0.000164	0.000518	CcSEcCtD
Brinzolamide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000164	0.000518	CcSEcCtD
Brinzolamide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000164	0.000518	CcSEcCtD
Brinzolamide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000164	0.000518	CcSEcCtD
Brinzolamide—Headache—Glyburide—type 2 diabetes mellitus	0.000163	0.000515	CcSEcCtD
Brinzolamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000162	0.000513	CcSEcCtD
Brinzolamide—Hypotension—Losartan—type 2 diabetes mellitus	0.000162	0.000512	CcSEcCtD
Brinzolamide—Palpitations—Ramipril—type 2 diabetes mellitus	0.000161	0.000509	CcSEcCtD
Brinzolamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000161	0.000509	CcSEcCtD
Brinzolamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00016	0.000506	CcSEcCtD
Brinzolamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00016	0.000505	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000159	0.000503	CcSEcCtD
Brinzolamide—Cough—Ramipril—type 2 diabetes mellitus	0.000159	0.000503	CcSEcCtD
Brinzolamide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000159	0.000502	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000158	0.0005	CcSEcCtD
Brinzolamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000158	0.000499	CcSEcCtD
Brinzolamide—Pain—Irbesartan—type 2 diabetes mellitus	0.000158	0.000498	CcSEcCtD
Brinzolamide—Insomnia—Losartan—type 2 diabetes mellitus	0.000157	0.000496	CcSEcCtD
Brinzolamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000156	0.000494	CcSEcCtD
Brinzolamide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000156	0.000492	CcSEcCtD
Brinzolamide—Urticaria—Metformin—type 2 diabetes mellitus	0.000155	0.00049	CcSEcCtD
Brinzolamide—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000155	0.00049	CcSEcCtD
Brinzolamide—Myalgia—Ramipril—type 2 diabetes mellitus	0.000155	0.00049	CcSEcCtD
Brinzolamide—Chest pain—Ramipril—type 2 diabetes mellitus	0.000155	0.00049	CcSEcCtD
Brinzolamide—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000155	0.000489	CcSEcCtD
Brinzolamide—Nausea—Glyburide—type 2 diabetes mellitus	0.000155	0.000488	CcSEcCtD
Brinzolamide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000155	0.000488	CcSEcCtD
Brinzolamide—Somnolence—Losartan—type 2 diabetes mellitus	0.000154	0.000487	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000154	0.000487	CcSEcCtD
Brinzolamide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000154	0.000486	CcSEcCtD
Brinzolamide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000153	0.000485	CcSEcCtD
Brinzolamide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000153	0.000483	CcSEcCtD
Brinzolamide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000152	0.000481	CcSEcCtD
Brinzolamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000152	0.00048	CcSEcCtD
Brinzolamide—Pruritus—Valsartan—type 2 diabetes mellitus	0.000152	0.00048	CcSEcCtD
Brinzolamide—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000152	0.00048	CcSEcCtD
Brinzolamide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000151	0.000477	CcSEcCtD
Brinzolamide—Pruritus—Orlistat—type 2 diabetes mellitus	0.00015	0.000474	CcSEcCtD
Brinzolamide—Fatigue—Losartan—type 2 diabetes mellitus	0.00015	0.000473	CcSEcCtD
Brinzolamide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000149	0.000469	CcSEcCtD
Brinzolamide—Pain—Losartan—type 2 diabetes mellitus	0.000149	0.000469	CcSEcCtD
Brinzolamide—Rash—Gliclazide—type 2 diabetes mellitus	0.000147	0.000465	CcSEcCtD
Brinzolamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000147	0.000465	CcSEcCtD
Brinzolamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000147	0.000464	CcSEcCtD
Brinzolamide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000147	0.000463	CcSEcCtD
Brinzolamide—Headache—Gliclazide—type 2 diabetes mellitus	0.000146	0.000462	CcSEcCtD
Brinzolamide—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000146	0.000461	CcSEcCtD
Brinzolamide—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000145	0.000459	CcSEcCtD
Brinzolamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000145	0.000458	CcSEcCtD
Brinzolamide—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000145	0.000457	CcSEcCtD
Brinzolamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000143	0.000452	CcSEcCtD
Brinzolamide—Dizziness—Valsartan—type 2 diabetes mellitus	0.000142	0.000448	CcSEcCtD
Brinzolamide—Dizziness—Orlistat—type 2 diabetes mellitus	0.00014	0.000443	CcSEcCtD
Brinzolamide—Asthenia—Metformin—type 2 diabetes mellitus	0.00014	0.000443	CcSEcCtD
Brinzolamide—Hypotension—Ramipril—type 2 diabetes mellitus	0.000139	0.000439	CcSEcCtD
Brinzolamide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000139	0.000438	CcSEcCtD
Brinzolamide—Pruritus—Metformin—type 2 diabetes mellitus	0.000138	0.000437	CcSEcCtD
Brinzolamide—Urticaria—Losartan—type 2 diabetes mellitus	0.000138	0.000436	CcSEcCtD
Brinzolamide—Vomiting—Valsartan—type 2 diabetes mellitus	0.000137	0.000431	CcSEcCtD
Brinzolamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000136	0.000429	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000136	0.000428	CcSEcCtD
Brinzolamide—Rash—Valsartan—type 2 diabetes mellitus	0.000135	0.000427	CcSEcCtD
Brinzolamide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000135	0.000427	CcSEcCtD
Brinzolamide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000135	0.000426	CcSEcCtD
Brinzolamide—Insomnia—Ramipril—type 2 diabetes mellitus	0.000135	0.000425	CcSEcCtD
Brinzolamide—Headache—Valsartan—type 2 diabetes mellitus	0.000135	0.000425	CcSEcCtD
Brinzolamide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000134	0.000422	CcSEcCtD
Brinzolamide—Rash—Orlistat—type 2 diabetes mellitus	0.000134	0.000422	CcSEcCtD
Brinzolamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000134	0.000422	CcSEcCtD
Brinzolamide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000134	0.000422	CcSEcCtD
Brinzolamide—Headache—Orlistat—type 2 diabetes mellitus	0.000133	0.00042	CcSEcCtD
Brinzolamide—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000133	0.000419	CcSEcCtD
Brinzolamide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000132	0.000418	CcSEcCtD
Brinzolamide—Somnolence—Ramipril—type 2 diabetes mellitus	0.000132	0.000418	CcSEcCtD
Brinzolamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000131	0.000414	CcSEcCtD
Brinzolamide—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000131	0.000412	CcSEcCtD
Brinzolamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000129	0.000409	CcSEcCtD
Brinzolamide—Dizziness—Metformin—type 2 diabetes mellitus	0.000129	0.000408	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000129	0.000406	CcSEcCtD
Brinzolamide—Fatigue—Ramipril—type 2 diabetes mellitus	0.000128	0.000405	CcSEcCtD
Brinzolamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000128	0.000404	CcSEcCtD
Brinzolamide—Nausea—Valsartan—type 2 diabetes mellitus	0.000128	0.000403	CcSEcCtD
Brinzolamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000126	0.000399	CcSEcCtD
Brinzolamide—Nausea—Orlistat—type 2 diabetes mellitus	0.000126	0.000398	CcSEcCtD
Brinzolamide—Asthenia—Losartan—type 2 diabetes mellitus	0.000125	0.000393	CcSEcCtD
Brinzolamide—Vomiting—Metformin—type 2 diabetes mellitus	0.000124	0.000393	CcSEcCtD
Brinzolamide—Rash—Metformin—type 2 diabetes mellitus	0.000123	0.000389	CcSEcCtD
Brinzolamide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000123	0.000389	CcSEcCtD
Brinzolamide—Pruritus—Losartan—type 2 diabetes mellitus	0.000123	0.000388	CcSEcCtD
Brinzolamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000123	0.000387	CcSEcCtD
Brinzolamide—Headache—Metformin—type 2 diabetes mellitus	0.000123	0.000387	CcSEcCtD
Brinzolamide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000122	0.000385	CcSEcCtD
Brinzolamide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000119	0.000375	CcSEcCtD
Brinzolamide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000118	0.000373	CcSEcCtD
Brinzolamide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000117	0.00037	CcSEcCtD
Brinzolamide—Rash—Irbesartan—type 2 diabetes mellitus	0.000116	0.000367	CcSEcCtD
Brinzolamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000116	0.000367	CcSEcCtD
Brinzolamide—Nausea—Metformin—type 2 diabetes mellitus	0.000116	0.000367	CcSEcCtD
Brinzolamide—Headache—Irbesartan—type 2 diabetes mellitus	0.000116	0.000365	CcSEcCtD
Brinzolamide—Dizziness—Losartan—type 2 diabetes mellitus	0.000115	0.000363	CcSEcCtD
Brinzolamide—Vomiting—Losartan—type 2 diabetes mellitus	0.00011	0.000349	CcSEcCtD
Brinzolamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00011	0.000346	CcSEcCtD
Brinzolamide—Nausea—Irbesartan—type 2 diabetes mellitus	0.00011	0.000346	CcSEcCtD
Brinzolamide—Rash—Losartan—type 2 diabetes mellitus	0.000109	0.000346	CcSEcCtD
Brinzolamide—Dermatitis—Losartan—type 2 diabetes mellitus	0.000109	0.000345	CcSEcCtD
Brinzolamide—Headache—Losartan—type 2 diabetes mellitus	0.000109	0.000343	CcSEcCtD
Brinzolamide—Asthenia—Ramipril—type 2 diabetes mellitus	0.000107	0.000337	CcSEcCtD
Brinzolamide—Pruritus—Ramipril—type 2 diabetes mellitus	0.000105	0.000333	CcSEcCtD
Brinzolamide—Nausea—Losartan—type 2 diabetes mellitus	0.000103	0.000326	CcSEcCtD
Brinzolamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000102	0.000322	CcSEcCtD
Brinzolamide—Dizziness—Ramipril—type 2 diabetes mellitus	9.85e-05	0.000311	CcSEcCtD
Brinzolamide—Vomiting—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000299	CcSEcCtD
Brinzolamide—Rash—Ramipril—type 2 diabetes mellitus	9.39e-05	0.000296	CcSEcCtD
Brinzolamide—Dermatitis—Ramipril—type 2 diabetes mellitus	9.38e-05	0.000296	CcSEcCtD
Brinzolamide—Headache—Ramipril—type 2 diabetes mellitus	9.33e-05	0.000295	CcSEcCtD
Brinzolamide—Nausea—Ramipril—type 2 diabetes mellitus	8.85e-05	0.000279	CcSEcCtD
Brinzolamide—CA1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.92e-05	0.000346	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CTGF—type 2 diabetes mellitus	3.9e-05	0.000345	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AGT—type 2 diabetes mellitus	3.88e-05	0.000342	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AGT—type 2 diabetes mellitus	3.88e-05	0.000342	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HMGCR—type 2 diabetes mellitus	3.87e-05	0.000341	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CALM1—type 2 diabetes mellitus	3.81e-05	0.000337	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CALM1—type 2 diabetes mellitus	3.81e-05	0.000337	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—APOE—type 2 diabetes mellitus	3.8e-05	0.000335	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—APOE—type 2 diabetes mellitus	3.8e-05	0.000335	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.78e-05	0.000334	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—MTHFR—type 2 diabetes mellitus	3.78e-05	0.000334	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—APOA1—type 2 diabetes mellitus	3.75e-05	0.000331	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—APOA1—type 2 diabetes mellitus	3.75e-05	0.000331	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PPARA—type 2 diabetes mellitus	3.71e-05	0.000327	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GNB3—type 2 diabetes mellitus	3.68e-05	0.000325	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.68e-05	0.000325	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HMOX1—type 2 diabetes mellitus	3.66e-05	0.000323	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PPARG—type 2 diabetes mellitus	3.64e-05	0.000321	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.64e-05	0.000321	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CAT—type 2 diabetes mellitus	3.61e-05	0.000319	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.59e-05	0.000317	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.59e-05	0.000317	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AGT—type 2 diabetes mellitus	3.59e-05	0.000317	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	3.58e-05	0.000316	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—INS—type 2 diabetes mellitus	3.57e-05	0.000315	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PPARG—type 2 diabetes mellitus	3.54e-05	0.000313	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PPARG—type 2 diabetes mellitus	3.54e-05	0.000313	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	3.54e-05	0.000312	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CALM1—type 2 diabetes mellitus	3.53e-05	0.000312	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	3.53e-05	0.000312	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GNB3—type 2 diabetes mellitus	3.52e-05	0.000311	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.52e-05	0.000311	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—APOE—type 2 diabetes mellitus	3.52e-05	0.000311	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—IL6—type 2 diabetes mellitus	3.51e-05	0.00031	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HMOX1—type 2 diabetes mellitus	3.51e-05	0.00031	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.51e-05	0.00031	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—APOB—type 2 diabetes mellitus	3.51e-05	0.00031	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	3.49e-05	0.000308	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—APOA1—type 2 diabetes mellitus	3.48e-05	0.000307	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—INS—type 2 diabetes mellitus	3.47e-05	0.000307	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—INS—type 2 diabetes mellitus	3.47e-05	0.000307	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CAT—type 2 diabetes mellitus	3.46e-05	0.000306	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.45e-05	0.000304	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GCG—type 2 diabetes mellitus	3.45e-05	0.000304	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTM1—type 2 diabetes mellitus	3.41e-05	0.000301	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GNB3—type 2 diabetes mellitus	3.38e-05	0.000298	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.38e-05	0.000298	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HMOX1—type 2 diabetes mellitus	3.36e-05	0.000297	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—APOB—type 2 diabetes mellitus	3.36e-05	0.000297	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—LPL—type 2 diabetes mellitus	3.35e-05	0.000296	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CAT—type 2 diabetes mellitus	3.32e-05	0.000293	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PPARG—type 2 diabetes mellitus	3.31e-05	0.000292	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PPARG—type 2 diabetes mellitus	3.31e-05	0.000292	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ADCY5—type 2 diabetes mellitus	3.28e-05	0.000289	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ALB—type 2 diabetes mellitus	3.27e-05	0.000289	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTM1—type 2 diabetes mellitus	3.27e-05	0.000289	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GPX1—type 2 diabetes mellitus	3.27e-05	0.000288	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—INS—type 2 diabetes mellitus	3.24e-05	0.000286	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—INS—type 2 diabetes mellitus	3.24e-05	0.000286	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—APOB—type 2 diabetes mellitus	3.22e-05	0.000285	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—LPL—type 2 diabetes mellitus	3.21e-05	0.000283	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ALB—type 2 diabetes mellitus	3.19e-05	0.000281	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ALB—type 2 diabetes mellitus	3.19e-05	0.000281	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CD36—type 2 diabetes mellitus	3.18e-05	0.000281	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ADCY5—type 2 diabetes mellitus	3.14e-05	0.000277	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.14e-05	0.000277	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTM1—type 2 diabetes mellitus	3.13e-05	0.000277	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GPX1—type 2 diabetes mellitus	3.13e-05	0.000276	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3R1—type 2 diabetes mellitus	3.13e-05	0.000276	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NOS3—type 2 diabetes mellitus	3.13e-05	0.000276	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—LPL—type 2 diabetes mellitus	3.08e-05	0.000272	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PPARG—type 2 diabetes mellitus	3.06e-05	0.000271	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CD36—type 2 diabetes mellitus	3.05e-05	0.000269	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.05e-05	0.000269	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3R1—type 2 diabetes mellitus	3.05e-05	0.000269	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NOS3—type 2 diabetes mellitus	3.05e-05	0.000269	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NOS3—type 2 diabetes mellitus	3.05e-05	0.000269	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—MTHFR—type 2 diabetes mellitus	3.01e-05	0.000266	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ADCY5—type 2 diabetes mellitus	3.01e-05	0.000266	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.01e-05	0.000266	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—INS—type 2 diabetes mellitus	3.01e-05	0.000265	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GPX1—type 2 diabetes mellitus	3e-05	0.000265	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALB—type 2 diabetes mellitus	2.97e-05	0.000263	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALB—type 2 diabetes mellitus	2.97e-05	0.000263	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GNB3—type 2 diabetes mellitus	2.97e-05	0.000262	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.97e-05	0.000262	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HMOX1—type 2 diabetes mellitus	2.96e-05	0.000261	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARA—type 2 diabetes mellitus	2.96e-05	0.000261	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CD36—type 2 diabetes mellitus	2.92e-05	0.000258	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CAT—type 2 diabetes mellitus	2.92e-05	0.000258	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—MTHFR—type 2 diabetes mellitus	2.89e-05	0.000255	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.89e-05	0.000255	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AGT—type 2 diabetes mellitus	2.86e-05	0.000253	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—type 2 diabetes mellitus	2.86e-05	0.000253	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3R1—type 2 diabetes mellitus	2.84e-05	0.000251	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NOS3—type 2 diabetes mellitus	2.84e-05	0.000251	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NOS3—type 2 diabetes mellitus	2.84e-05	0.000251	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3R1—type 2 diabetes mellitus	2.84e-05	0.000251	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARA—type 2 diabetes mellitus	2.83e-05	0.00025	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—APOB—type 2 diabetes mellitus	2.83e-05	0.00025	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CALM1—type 2 diabetes mellitus	2.82e-05	0.000249	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—APOE—type 2 diabetes mellitus	2.81e-05	0.000248	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—type 2 diabetes mellitus	2.79e-05	0.000246	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—type 2 diabetes mellitus	2.79e-05	0.000246	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—APOA1—type 2 diabetes mellitus	2.77e-05	0.000245	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—MTHFR—type 2 diabetes mellitus	2.77e-05	0.000245	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTM1—type 2 diabetes mellitus	2.76e-05	0.000243	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALB—type 2 diabetes mellitus	2.76e-05	0.000243	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AGT—type 2 diabetes mellitus	2.75e-05	0.000242	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARA—type 2 diabetes mellitus	2.72e-05	0.00024	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.71e-05	0.00024	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—LPL—type 2 diabetes mellitus	2.7e-05	0.000239	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CALM1—type 2 diabetes mellitus	2.7e-05	0.000238	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—APOE—type 2 diabetes mellitus	2.69e-05	0.000238	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.67e-05	0.000236	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—APOA1—type 2 diabetes mellitus	2.66e-05	0.000235	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ADCY5—type 2 diabetes mellitus	2.65e-05	0.000234	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GPX1—type 2 diabetes mellitus	2.64e-05	0.000233	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3R1—type 2 diabetes mellitus	2.64e-05	0.000233	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NOS3—type 2 diabetes mellitus	2.64e-05	0.000233	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AGT—type 2 diabetes mellitus	2.63e-05	0.000232	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—type 2 diabetes mellitus	2.6e-05	0.00023	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—type 2 diabetes mellitus	2.6e-05	0.00023	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CALM1—type 2 diabetes mellitus	2.59e-05	0.000229	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—APOE—type 2 diabetes mellitus	2.58e-05	0.000228	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CD36—type 2 diabetes mellitus	2.57e-05	0.000227	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—APOA1—type 2 diabetes mellitus	2.55e-05	0.000225	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.54e-05	0.000224	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARG—type 2 diabetes mellitus	2.44e-05	0.000216	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MTHFR—type 2 diabetes mellitus	2.43e-05	0.000215	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—type 2 diabetes mellitus	2.41e-05	0.000213	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—INS—type 2 diabetes mellitus	2.4e-05	0.000212	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARA—type 2 diabetes mellitus	2.39e-05	0.000211	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARG—type 2 diabetes mellitus	2.34e-05	0.000207	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AGT—type 2 diabetes mellitus	2.31e-05	0.000204	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—INS—type 2 diabetes mellitus	2.3e-05	0.000203	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CALM1—type 2 diabetes mellitus	2.27e-05	0.000201	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—APOE—type 2 diabetes mellitus	2.27e-05	0.0002	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARG—type 2 diabetes mellitus	2.25e-05	0.000198	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—APOA1—type 2 diabetes mellitus	2.24e-05	0.000198	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—INS—type 2 diabetes mellitus	2.2e-05	0.000195	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALB—type 2 diabetes mellitus	2.2e-05	0.000194	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALB—type 2 diabetes mellitus	2.11e-05	0.000186	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NOS3—type 2 diabetes mellitus	2.1e-05	0.000186	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.1e-05	0.000186	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.07e-05	0.000183	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALB—type 2 diabetes mellitus	2.02e-05	0.000178	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NOS3—type 2 diabetes mellitus	2.01e-05	0.000178	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.01e-05	0.000178	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARG—type 2 diabetes mellitus	1.97e-05	0.000174	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—INS—type 2 diabetes mellitus	1.94e-05	0.000171	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.93e-05	0.000171	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NOS3—type 2 diabetes mellitus	1.93e-05	0.000171	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—type 2 diabetes mellitus	1.92e-05	0.00017	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—type 2 diabetes mellitus	1.84e-05	0.000163	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.81e-05	0.00016	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.81e-05	0.00016	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALB—type 2 diabetes mellitus	1.78e-05	0.000157	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—type 2 diabetes mellitus	1.77e-05	0.000156	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.71e-05	0.000151	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.71e-05	0.000151	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-05	0.00015	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-05	0.00015	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.64e-05	0.000144	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—type 2 diabetes mellitus	1.55e-05	0.000137	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.51e-05	0.000133	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.51e-05	0.000133	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.46e-05	0.000129	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.46e-05	0.000129	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.46e-05	0.000129	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.46e-05	0.000129	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.46e-05	0.000129	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKT1—type 2 diabetes mellitus	1.44e-05	0.000127	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.41e-05	0.000125	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKT1—type 2 diabetes mellitus	1.4e-05	0.000124	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKT1—type 2 diabetes mellitus	1.4e-05	0.000124	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.33e-05	0.000118	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.33e-05	0.000118	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKT1—type 2 diabetes mellitus	1.31e-05	0.000115	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKT1—type 2 diabetes mellitus	1.31e-05	0.000115	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.3e-05	0.000115	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.24e-05	0.000109	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.24e-05	0.000109	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.24e-05	0.000109	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKT1—type 2 diabetes mellitus	1.21e-05	0.000107	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.19e-05	0.000105	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.19e-05	0.000105	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.14e-05	0.000101	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.14e-05	0.000101	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.12e-05	9.92e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.1e-05	9.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.1e-05	9.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.1e-05	9.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.04e-05	9.17e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.72e-06	8.59e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKT1—type 2 diabetes mellitus	9.66e-06	8.53e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.39e-06	8.29e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.39e-06	8.29e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.39e-06	8.29e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.39e-06	8.29e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKT1—type 2 diabetes mellitus	9.26e-06	8.18e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	9e-06	7.95e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKT1—type 2 diabetes mellitus	8.88e-06	7.84e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.37e-06	7.39e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.81e-06	6.9e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKT1—type 2 diabetes mellitus	7.81e-06	6.89e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.66e-06	6.76e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.66e-06	6.76e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.51e-06	6.63e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.46e-06	6.59e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.46e-06	6.59e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.46e-06	6.59e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.41e-06	6.55e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.28e-06	6.43e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	7.2e-06	6.36e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.69e-06	5.91e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.69e-06	5.91e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.69e-06	5.91e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.57e-06	5.8e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.51e-06	5.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.37e-06	5.63e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	6.12e-06	5.4e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.05e-06	5.34e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.05e-06	5.34e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.8e-06	5.12e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.8e-06	5.12e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5e-06	4.42e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5e-06	4.42e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.98e-06	4.4e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.91e-06	4.34e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.77e-06	4.21e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.64e-06	4.1e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.55e-06	4.02e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.46e-06	3.94e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.44e-06	3.92e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.33e-06	3.82e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.27e-06	3.77e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.1e-06	3.62e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.02e-06	3.55e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.89e-06	3.44e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.83e-06	3.38e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.82e-06	3.37e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.77e-06	3.33e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.32e-06	2.94e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.26e-06	2.88e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.99e-06	2.64e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.86e-06	2.52e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.86e-06	2.52e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.61e-06	2.31e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.31e-06	1.16e-05	CbGpPWpGaD
